Advertisement
U.S. markets closed

GL Pharm Tech Corp. (204840.KQ)

KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
1,366.00+51.00 (+3.88%)
At close: 03:30PM KST
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
26,033,025
26,033,025
16,728,503
12,425,741
11,988,208
Cost of Revenue
17,323,543
17,323,543
11,851,684
8,657,068
8,676,877
Gross Profit
8,709,482
8,709,482
4,876,819
3,768,674
3,311,331
Operating Expense
11,937,494
11,937,494
8,131,569
6,463,100
5,956,447
Operating Income
-3,228,012
-3,228,012
-3,254,750
-2,694,426
-2,645,116
Net Non Operating Interest Income Expense
-671,617
-671,617
-350,521
-849,764
-783,304
Pretax Income
-3,944,290
-3,944,290
-832,445
-3,841,681
-3,467,071
Tax Provision
-195,776
-195,776
-42,277
-107,437
-110,600
Net Income Common Stockholders
-3,748,515
-3,748,515
-790,167
-3,727,370
-3,356,471
Basic EPS
-31.00
-
-13.00
-73.00
-75.00
Diluted EPS
-31.00
-
-13.00
-73.00
-75.00
Basic Average Shares
62,354
-
60,782
51,060
44,753
Diluted Average Shares
62,354
-
60,782
51,060
44,753
Total Operating Income as Reported
-3,228,012
-3,228,012
-3,254,750
-2,694,427
-2,645,116
Rent Expense Supplemental
18,147
18,147
8,467
9,006
2,031
Total Expenses
29,261,037
29,261,037
19,983,253
15,120,168
14,633,324
Net Income from Continuing & Discontinued Operation
-3,748,515
-3,748,515
-790,167
-3,727,370
-3,356,471
Normalized Income
-3,224,535
-3,224,535
-2,416,690
-3,420,825
-3,364,840
Interest Income
111,268
111,268
74,896
17,115
44,190
Interest Expense
782,885
782,885
425,417
866,879
827,494
Net Interest Income
-671,617
-671,617
-350,521
-849,764
-783,304
EBIT
-3,161,405
-3,161,405
-407,028
-2,974,802
-2,639,577
EBITDA
-1,023,304
-1,023,304
1,737,719
-934,872
-690,855
Reconciled Cost of Revenue
17,323,543
17,323,543
11,851,684
8,657,068
8,676,877
Reconciled Depreciation
2,138,101
2,138,101
2,144,747
2,039,930
1,948,722
Net Income from Continuing Operation Net Minority Interest
-3,748,515
-3,748,515
-790,167
-3,727,370
-3,356,471
Total Unusual Items Excluding Goodwill
-551,346
-551,346
1,713,548
-315,365
8,645
Total Unusual Items
-551,346
-551,346
1,713,548
-315,365
8,645
Normalized EBITDA
-471,958
-471,958
24,171
-619,507
-699,500
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-27,366
-27,366
87,026
-8,820
275.7773